Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IdB 1016 in Hepatitis C
NCT00055445Phase 2Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Nov 2003
- Modality
- Drug Delivery Systems, Nucleic Acid-Directed Small Molecules, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silybin + phosphatidylcholine in hepatitis C virus infection, sponsored by National Center for Complementary and Integrative Health. Started Nov 2003; status: completed.
02
Drugs
silybin + phosphatidylcholine
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00055445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00055445.